Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 58, Issue 12, 2009, Pages 1753-1761

  Mostad, Ingrid L ^a,b   Bjerve, Kristian S ^a   Basu, Samar ^c   Sutton, Pauline ^d   Frayn, Keith N ^d   Grill, Valdemar ^a,b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C PEPTIDE; INTRALIPID; ISOPROSTANE DERIVATIVE; LEPTIN; OMEGA 3 FATTY ACID; OMEGAVEN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CALORIMETRY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; ENERGY METABOLISM; ENERGY YIELD; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE UTILIZATION; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; INTERMETHOD COMPARISON; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BIOLOGICAL MARKERS; BODY COMPOSITION; C-PEPTIDE; CALORIMETRY, INDIRECT; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIET; DINOPROST; DOUBLE-BLIND METHOD; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, NONESTERIFIED; FATTY ACIDS, OMEGA-3; FEMALE; GLUCAGON; GLUCOSE CLAMP TECHNIQUE; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; INSULIN RESISTANCE; ISOPROSTANES; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 71849107962     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.06.003     Document Type: Article

References (32)

1. Psota T.L., Gebauer S.K., and Kris-Etherton P. Dietary omega-3 fatty acid intake and cardiovascular risk. Am J Cardiol 98 (2006) 3i-18i
2. Furst P., and Kuhn K.S. Fish oil emulsions: what benefits can they bring?. Clin Nutr 19 (2000) 7-14
3. Nordic Council of Ministers. Nordic nutrition recommendations: NNR 2004: integrating nutrition and physical activity (2005), Nordic Council of Ministers, Copenhagen
4. Gebauer S.K., Psota T.L., Harris W.S., and Kris-Etherton P.M. n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 83 6 Suppl (2006) 1526S-1535S
5. Mann J.I., De Leeuw I., Hermansen K., Karamanos B., Karlstrom B., Katsilambros N., et al. Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis 14 (2004) 373-394
6. Mostad I.L., Bjerve K.S., Bjorgaas M.R., Lydersen S., and Grill V. Effects of n-3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation. Am J Clin Nutr 84 (2006) 540-550
7. Nalsen C., Vessby B., Berglund L., Uusitupa M., Hermansen K., Riccardi G., et al. Dietary (n-3) fatty acids reduce plasma F2-isoprostanes but not prostaglandin F2alpha in healthy humans. J Nutr 136 (2006) 1222-1228
8. Storgaard H., Jensen C.B., Vaag A.A., Volund A., and Madsbad S. Insulin secretion after short- and long-term low-grade free fatty acid infusion in men with increased risk of developing type 2 diabetes. Metabolism 52 (2003) 885-894
9. Leung N., Sakaue T., Carpentier A., Uffelman K., Giacca A., and Lewis G.F. Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24 hours of moderate hyperglycaemia on insulin sensitivity and pancreatic beta-cell function in obese men. Diabetologia 47 (2004) 204-213
10. Boden G., and Chen X. Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J Clin Invest 96 (1995) 1261-1268
11. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46 (1997) 3-10
12. Bergman R.N., Finegood D.T., and Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev 6 (1985) 45-86
13. Faber O.K., and Binder C. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus. Diabetes 26 (1977) 605-610
14. Ferrannini E. The theoretical bases of indirect calorimetry: a review. Metabolism 37 (1988) 287-301
15. Takala J., and Meriläinen P. Handbook of gas exchange and indirect calorimetry (2001), Datex-Engström Division, Helsinki
16. Rimestad A.H., Borgenjordet Å., and Vesterhus K.N. Den store matvaretabellen (The Norwegian food table) (2001), Universitetsforlaget, Oslo
17. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
18. Burdge G.C., Wright P., Jones A.E., and Wootton S.A. A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction. Br J Nutr 84 (2000) 781-787
19. Riserus U., Sprecher D., Johnson T., Olson E., Hirschberg S., Liu A., et al. Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men. Diabetes 57 (2008) 332-339
20. Bonaa K.H., Bjerve K.S., Straume B., Gram I.T., and Thelle D. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromso study. N Engl J Med 322 (1990) 795-801
21. Basu S. Radioimmunoassay of 8-iso-prostaglandin F2alpha: an index for oxidative injury via free radical catalysed lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids 58 (1998) 319-325
22. Lee K.U., Lee H.K., Koh C.S., and Min H.K. Artificial induction of intravascular lipolysis by lipid-heparin infusion leads to insulin resistance in man. Diabetologia 31 (1988) 285-290
23. Boden G., Chen X., Rosner J., and Barton M. Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 44 (1995) 1239-1242
24. Boden G. Free fatty acids and insulin secretion in humans. Curr Diab Rep 5 (2005) 167-170
25. Wendel M., Rössel T., Bergmann S., Otto S., Ragaller M., Zimmermann T., et al. Impact of total parenteral nutrition including omega-3 fatty acids on the regulation of plasma lipoproteins and glycemic control after major abdominal surgery. e-SPEN, Eur e-J Clin Nutr Metab 2 (2007) e103-e110
26. Hodson L., McQuaid S.E., Karpe F., Frayn K.N., and Fielding B.A. Differences in partitioning of meal fatty acids into blood lipid fractions: a comparison of linoleate, oleate, and palmitate. Am J Physiol Endocrinol Metab 296 (2009) E64-71
27. Jequier E., and Felber J.P. Indirect calorimetry. Baillieres Clin Endocrinol Metab 1 (1987) 911-935
28. Boden G., Jadali F., White J., Liang Y., Mozzoli M., Chen X., et al. Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest 88 (1991) 960-966
29. Tappy L., Berger M.M., Schwarz J.M., Schneiter P., Kim S., Revelly J.P., et al. Metabolic effects of parenteral nutrition enriched with n-3 polyunsaturated fatty acids in critically ill patients. Clin Nutr 25 (2006) 588-595
30. Stojiljkovic M.P., Lopes H.F., Zhang D., Morrow J.D., Goodfriend T.L., and Egan B.M. Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster. J Hypertens 20 (2002) 1215-1221
31. Lopes H.F., Morrow J.D., Stojiljkovic M.P., Goodfriend T.L., and Egan B.M. Acute hyperlipidemia increases oxidative stress more in African Americans than in white Americans. Am J Hypertens 16 5 Pt 1 (2003) 331-336
32. Basu S. Isoprostanes: novel bioactive products of lipid peroxidation. Free Radic Res 38 (2004) 105-122